Early inflammation-associated factors blunt sterol regulatory element-binding proteins-1-mediated lipogenesis in high-fat diet-fed APPSWE/PSEN1dE9 mouse model of Alzheimer's disease

Journal of Neurochemistry

Volumn 136, Issue 4, 2016, Pages 791-803

  Tang, Ying ^a   Peng, Yunhua ^a   Liu, Jing ^a   Shi, Le ^a   Wang, Yongyao ^a   Long, Jiangang ^a   Liu, Jiankang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; hepatic steatosis; high fat diet; inflammation; type 2 diabetes

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; INTERLEUKIN 6; LIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GENOTYPE; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; HEPATITIS; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; LIPOGENESIS; LIVER CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 84956593481     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13437     Document Type: Article

References (39)

1. Akiyama H., Barger S., Barnum S., et al,. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421.
2. Axelsen L. N., Lademann J. B., Petersen J. S., Holstein-Rathlou N. H., Ploug T., Prats C., Pedersen H. D., and, Kjolbye A. L., (2010) Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1560-R1570.
3. Biddinger S. B., and, Kahn C. R., (2006) From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123-158.
4. Ferri C. P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., and, Huang Y., (2006) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117.
5. Foretz M., Pacot C., Dugail I., et al,. (1999) ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol. Cell. Biol. 19, 3760-3768.
6. Goldstein J. L., and, Brown M. S., (2009) The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29, 431-438.
7. Gonzalez-Dominguez R., Garcia-Barrera T., Vitorica J., and, Gomez-Ariza J. L., (2015a) High throughput multiorgan metabolomics in the APP/PS1 mouse model of Alzheimer's disease. Electrophoresis 36, 2237-2249.
8. Gonzalez-Dominguez R., Garcia-Barrera T., Vitorica J., and, Gomez-Ariza J. L., (2015b) Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model. Mol. BioSyst. 11, 2429-2440.
9. Groen A. K., Bloks V. W., Verkade H., and, Kuipers F., (2014) Cross-talk between liver and intestine in control of cholesterol and energy homeostasis. Mol. Aspects Med. 37C, 77-88.
10. Han C., Wang J., Li L., Zhang Z., Wang L., and, Pan Z., (2009) The role of insulin and glucose in goose primary hepatocyte triglyceride accumulation. J. Exp. Biol. 212, 1553-1558.
11. Horton J. D., Goldstein J. L., and, Brown M. S., (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131.
12. Janson J., Laedtke T., Parisi J. E., O'Brien P., Petersen R. C., and, Butler P. C., (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474-481.
13. Jiang N., Yan X., Zhou W., Zhang Q., Chen H., Zhang Y., and, Zhang X., (2008) NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse. J. Proteome Res. 7, 3678-3686.
14. Kalaria R. N., Maestre G. E., Arizaga R., Friedland R. P., Galasko D., Hall K., Luchsinger J. A., Ogunniyi A., Perry E. K., and, Potocnik F., (2008) Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 7, 812-826.
15. Kent A. P., and, Stylianou I. M., (2011) Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis. Hepat. Med. 3, 29-44.
16. Kroy D. C., Beraza N., Tschaharganeh D. F., Sander L. E., Erschfeld S., Giebeler A., Liedtke C., Wasmuth H. E., Trautwein C., and, Streetz K. L., (2010) Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice. Hepatology 51, 463-473.
17. Kumashiro N., Beddow S. A., Vatner D. F., Majumdar S. K., Cantley J. L., Guebre-Egziabher F., Fat I., Guigni B., Jurczak M. J., and, Birkenfeld A. L., (2013) Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. Diabetes 62, 2183-2194.
18. Lawler Jr J. F., Yin M., Diehl A. M., Roberts E., and, Chatterjee S., (1998) Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J. Biol. Chem. 273, 5053-5059.
19. Maher P. A., and, Schubert D. R., (2009) Metabolic links between diabetes and Alzheimer's disease. Expert Rev. Neurother. 9, 617-630.
20. Malm T., Koistinaho J., and, Kanninen K., (2011) Utilization of APPswe/PS1dE9 transgenic mice in research of Alzheimer's disease: focus on gene therapy and cell-based therapy applications. Int. J. Alzheimers Dis. 2011, 517160.
21. McEwen B. S., Magariños A. M., Reagan L. P., (2002) Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes. J. Psychosom. Res. 53, 883-890.
22. Miller A. M., Wang H., Bertola A., Park O., Horiguchi N., Ki S. H., Yin S., Lafdil F., and, Gao B., (2011) Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice. Hepatology 54, 846-856.
23. Mody N., Agouni A., McIlroy G., Platt B., and, Delibegovic M., (2011) Susceptibility to diet-induced obesity and glucose intolerance in the APP SWE/PSEN1 A246E mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein. Diabetologia 54, 2143-2151.
24. Morris J. K., Honea R. A., Vidoni E. D., Swerdlow R. H., and, Burns J. M., (2014) Is Alzheimer's disease a systemic disease? Biochim. Biophys. Acta 1842, 1340-1349.
25. Ott A., Stolk R., Van Harskamp F., Pols H., Hofman A., and, Breteler M., (1999) Diabetes mellitus and the risk of dementia The Rotterdam Study. Neurology 53, 1937-1942.
26. Peng Y., Liu J., Tang Y., Han T., Han S., Li H., Hou C., and, Long J., (2014) High-fat-diet-induced weight gain ameliorates bone loss without exacerbating AbetaPP processing and cognition in female APP/PS1 mice. Front. Cell. Neurosci. 8, 225.
27. Postic C., Dentin R., and, Girard J., (2004) Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab. 30, 398-408.
28. Rosselli M. S., Burgueno A. L., Carabelli J., Schuman M., Pirola C. J., and, Sookoian S., (2009) Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis 206, 119-126.
29. Sato N., and, Morishita R., (2013) Plasma Aβ: a possible missing link between Alzheimer disease and diabetes. Diabetes 62, 1005-1006.
30. Sewter C., Berger D., Considine R. V., et al,. (2002) Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes 51, 1035-1041.
31. Swardfager W., Lanctot K., Rothenburg L., Wong A., Cappell J., and, Herrmann N., (2010) A meta-analysis of cytokines in Alzheimer's disease. Biol. Psychiatry 68, 930-941.
32. Takeda S., Sato N., Uchio-Yamada K., Sawada K., Kunieda T., Takeuchi D., Kurinami H., Shinohara M., Rakugi H., and, Morishita R., (2010) Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc. Natl Acad. Sci. USA 107, 7036-7041.
33. Tan Y., Lao W., Xiao L., Wang Z., Xiao W., Kamal M. A., Seale J. P., and, Qu X., (2013) Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats. Evid. Based Complement. Alternat. Med. 2013, 306738.
34. Ueki K., Kondo T., Tseng Y. H., and, Kahn C. R., (2004) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl Acad. Sci. USA 101, 10422-10427.
35. Wang C., Zhao Y., Gao X., et al,. (2015) Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. Hepatology 61, 870-882.
36. Wyss-Coray T., (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015.
37. Yin M., Wheeler M. D., Kono H., Bradford B. U., Gallucci R. M., Luster M. I., and, Thurman R. G., (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117, 942-952.
38. Zhang Y., Zhou B., Zhang F., Wu J., Hu Y., Liu Y., and, Zhai Q., (2012) Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway. Diabetes 61, 1434-1443.
39. Zhang Y., Zhou B., Deng B., Zhang F., Wu J., Wang Y., Le Y., and, Zhai Q., (2013) Amyloid-β induces hepatic insulin resistance in vivo via JAK2. Diabetes 62, 1159-1166.